Adenosine Kinase Expression in the Frontal Cortex in Schizophrenia
- 10 April 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Schizophrenia Bulletin
- Vol. 46 (3) , 690-698
Abstract
The adenosine hypothesis of schizophrenia posits that reduced availability of the neuromodulator adenosine contributes to dysregulation of dopamine and glutamate transmission and the symptoms associated with schizophrenia. It has been proposed that increased expression of the enzyme adenosine kinase (ADK) may drive hypofunction of the adenosine system. While animal models of ADK overexpression support such a role for altered ADK, the expression of ADK in schizophrenia has yet to be examined. In this study, we assayed ADK gene and protein expression in frontocortical tissue from schizophrenia subjects. In the dorsolateral prefrontal cortex (DLPFC), ADK-long and -short splice variant expression was not significantly altered in schizophrenia compared to controls. There was also no significant difference in ADK splice variant expression in the frontal cortex of rats treated chronically with haloperidol-decanoate, in a study to identify the effect of antipsychotics on ADK gene expression. ADK protein expression was not significantly altered in the DLPFC or anterior cingulate cortex (ACC). There was no significant effect of antipsychotic medication on ADK protein expression in the DLPFC or ACC. Overall, our results suggest that increased ADK expression does not contribute to hypofunction of the adenosine system in schizophrenia and that alternative mechanisms are involved in dysregulation of this system in schizophrenia.Keywords
Funding Information
- Lindsey Brinkmeyer Schizophrenia Research Fund (R01 MH094445)
This publication has 48 references indexed in Scilit:
- Transmembrane AMPA receptor regulatory protein (TARP) dysregulation in anterior cingulate cortex in schizophreniaSchizophrenia Research, 2013
- Adenosine augmentation ameliorates psychotic and cognitive endophenotypes of schizophreniaJournal of Clinical Investigation, 2012
- Adenosine hypothesis of schizophrenia – Opportunities for pharmacotherapyNeuropharmacology, 2012
- Adenosine Kinase Deficiency Disrupts the Methionine Cycle and Causes Hypermethioninemia, Encephalopathy, and Abnormal Liver FunctionThe American Journal of Human Genetics, 2011
- Upregulation of adenosine kinase in astrocytes in experimental and human temporal lobe epilepsyEpilepsia, 2011
- Molecular Characterization of Chinese Hamster Cells Mutants Affected in Adenosine Kinase and Showing Novel Genetic and Biochemical CharacteristicsBMC Biochemistry, 2011
- The Stanley Neuropathology Consortium Integrative Database: a Novel, Web-Based Tool for Exploring Neuropathological Markers in Psychiatric Disorders and the Biological Processes Associated with Abnormalities of Those MarkersNeuropsychopharmacology, 2009
- The Global Prevalence of SchizophreniaPLOS Medicine, 2005
- The Emerging Role of Glutamate in the Pathophysiology and Treatment of SchizophreniaAmerican Journal of Psychiatry, 2001
- Cloning and Expression of the Adenosine Kinase Gene from Rat and Human TissuesBiochemical and Biophysical Research Communications, 1997